$NVS with a Neutral outlook following its earnings #Stocks The PEAD projected a Neutral outlook for $NVS after a Positive Under reaction following its earnings release placing the stock in drift A with an expected accuracy of 100%.
NOTA trade ideas
Calling bullish on Novartis. NVSLooks like we have a an end to a zigzag here. Technically, we have not left FibChannel, hence the approach is risky. If the picture is right, we may see one or more impulses upwards. Wait and see.
We are not in the business of getting every prediction right, no one ever does and that is not the aim of the game. The Fibonacci targets are highlighted in green with invalidation in red. Fibonacci goals, it is prudent to suggest, are nothing more than mere fractally evident and therefore statistically likely levels that the market will go to. Having said that, the market will always do what it wants and always has a mind of its own. Therefore, none of this is financial advice, so do your own research and rely only on your own analysis. Trading is a true one man sport. Good luck out there and stay safe!
NVS - STOCKS - 27. OCT. 2021Welcome to our Weekly V2-Trade Setup ( NVS ) !
-
4 HOUR
Bearish market breakdown..
DAILY
Expecting another wave to the upside.
WEEKLY
Looking for a midterm push.
-
STOCK SETUP
BUY NVS
ENTRY LEVEL @ 83.15
SL @ 82.15
TP @ Open
Max Risk: 0.5% - 1%!
(Remember to add a few pips to all levels - different Brokers!)
Leave us a comment or like to keep our content for free and alive.
Have a great week everyone!
ALAN
$NVS with a Bullish outlook following its earnings #Stocks The PEAD projected a Bullish outlook for $NVS after a Positive over reaction following its earnings release placing the stock in drift B with an expected accuracy of 50%.
If you would like to see the Drift for another stock please message us. Also click on the Like Button if this was useful and follow us or join us.
NVS BullishCCI 74 crossing above -200 has been a very good bullish trade in the past, low end of the range and divergence on the CCI
Novartis AG (NOVN)The Swiss-based drugmaker missed consensus expectations on both earnings and sales in the first quarter, the results were hurt by a historically weak cough and cold season. Novartis’ cornerstone innovative medicines division turned in with sales +4%. Stock is currently pegged to underperform the broader market and our 18-month projections reflect below-average upside potential. But as said in the chart, a "buy and hold" strategy give a 3.50% dividend yield in CHF.
$NVS with a Bullish outlook following its earnings #Stocks The PEAD projected a Bullish outlook for $NVS after a Negative over reaction following its earnings release placing the stock in drift C
If you would like to see the Drift for another stock please message us. Also click on the Like Button if this was useful and follow us or join us.
NovartisNovartis (CHF81.02). Five-week high as share breaches downward trend line extending back to 25-Jan peak. Also, upside break of descending triangle while pivot is reclaimed.
$NV Swith a Neutral outlook following its earnings #Stocks The PEAD projected a Neutral outlook for $NVS after a Negative under reaction following its earnings release placing the stock in drift D
If you would like to see the Drift for another stock please message us. Also click on the Like Button if this was useful and follow us or join us.
NOVARTIS - LONG - DMI 55 AnalysisThe Directional Movement Index is showing Bullish sentiment on the DMI indicator and the EMA @ 55 fib.
If the Bears crossover the EMA then close long position.
Gives you excellent entry point with minimal stop loss.
NOVARTIS AG, NVS - 4.0% in 35 daysI understand the euphoria of picking on a winning horse and getting returns in excess of or even more than 100%, but what you need to pay attention to is money management and managing your positions.
You can buy stocks, you can buy futures, you can buy bonds and you can buy and/or sell options.
The key is always to use the instruments that we feel confident in and to have the ideal timing.
It is never just one of these two individually.
In this case, we have opened a position in our portfolio on Novartis (NVS), which will surely generate us a 4% return within a month.
Our goal is always a monthly return between 4%/5% monthly which on a compound growth we get an average of 50%/60% annually.
NYSE:NVS
Should re-test $98 in 2021NVS is a long term reliable dividend paying hold, but I try to be careful with pharmas. A lot of possible catalysts that can change the direction too soon.
This is purely a trend line analysis. I see good indicators from trend lines in play and looks like the stock will re test the $98 high again before either a move up or down. I expect it to break downward by 2022.
Caution: slow moving stock. It won't bleed your portfolio on red days, but watching paint dry would be a lot quicker than watching NVS go up a few percentage.
Good luck!
NVS (NYSE) - Go DownGreetings
Humbled, we would like to thanks for your support who has already liked, commented and followed us. Your support, strengthens us, to help in analyzing the market. If you have any questions, feel free to send us message (inbox).
Pra Trading :
- Please care for Money Management
- Have a good psychology
- Do not be hurry to open position and do not do nothing if u see opportunity
- Evaluate and upgrade your trading plan
Execution Strategy :
- Know what you want to buy, see the Fundamental
- Decide that you are on investing or speculating
- Consider what your strategy based on Investing/Speculating
- Make Road Map Of Your Trading Plan
- Decide
a. Entry strategy
b. Cut loss
c. Target of Profit
Post Trading :
a. Do not be sad if you loss or do not be very happy if you win
b. Just become a normal without emotion, Do not put emotion into your trading
c. Evaluate your trading
d. Keep on Learning
e. Be Humble
Idea :
NVS (NYSE) - Go Down
$NVS with a neutral outlook following its earnings #Stocks The PEAD projected a neutral outlook for $NVS after a negative under reaction following its earnings release placing the stock in drift D
If you would like to see the Drift for another stock please message us. Also click on the Like Button if this was useful and follow us or join us.
NOVN Long TradeNovartis showin higher lows or/and a inverse head shoulder, inside a right angled broadening wedge, with a partial decline, while showing hidden bullish divergence on all three oscilators MACD, RSI and Stochastic on the Daily timeframe.
Its at the perfect spot for entry a long entry.
Target 1: 94$
Target 2: 103$
Target 3: 115$
Looks Like NVS is in a nice Channel over the past 8 years. Watch for bounces off the bottom of the channel
NVS - EW analysis - ABC zigzag up NVS - It is in ABC zigzag wave up, where 3rd of C wave is in progress. Buy the three wave correction for next up move.
Give thumbs up if you really like the trade idea/analysis.
NVS BreakoutBreakout of inner range with 2R available to run to outer range. In general, breakout trades are expected to run longer than short term swing trades
R: $100
E: $93.4
S: $90.5
Diff: $2.90
T1 (1R): $96.3 (raise stop to $91.95 )
T2 (2R): $99.2 (withdraw 1/2, raise stop to Entry)
T3 (ATH): $106 OR Break of prior dip
$NVS Ready to Breakout?$NVS has been in a consolidation channel for 8 months now. It's tried and failed to breakout several times... I'm looking for this to break to the upside soon. With this much sideways action I have to think when it goes it should gain $10 to $15 in very short order. All TBD. I have an alert $0.10 above the last high at $92.20. Ideas, not investing / trading advice.
$nvs swing tradeThis one hasn't been above 70 on the RSI14 since the beginning of the year. It'll probably take a break for a few days.
NVS - Elliottwave analysis - Sell on bounceNVS - It is in 4th wave of C wave Y wave after the huge sell off.
sell on choppy bounce would be the trade set up in this case no matter what will be actual count in different alternates.
Give thumbs up if you really like the trade idea.
NOVN.vx bearish scenario:We have technical figure Triangle in Swiss company Novartis International AG (NOVN.vx) at daily chart. Novartis International AG is a Swiss multinational pharmaceutical company based in Basel, Switzerland. It is one of the largest pharmaceutical companies by both market capitalization and sales. The Triangle has broken through the support line at 16/10/2020, if the price holds below this level we can have possible bearish price movement with forecast for the next 16 days towards 74.78 CHF.
Fundamentals:
- Swiss drugmaker Novartis grabbed a key European panel’s recommendation for its prospective cholesterol drug Leqvio on Friday, clearing the way for its approval in the next couple of months. Novartis is also counting on approval from U.S. regulators before the end of the year for the drug, also known as inclisiran, which the Basel-based drugmaker bought in a deal last year for nearly $10 billion and predicts will be a top seller.
